A detailed history of Susquehanna International Group, LLP transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Susquehanna International Group, LLP holds 5,800 shares of RDY stock, worth $89,146. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,800
Previous 4,600 26.09%
Holding current value
$89,146
Previous $350,000 31.43%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$67.36 - $77.59 $37,991 - $43,760
-564 Reduced 13.08%
3,749 $274,000
Q4 2023

Feb 14, 2024

BUY
$64.27 - $69.9 $277,196 - $301,478
4,313 New
4,313 $300,000
Q2 2022

Aug 15, 2022

BUY
$49.62 - $58.13 $4,217 - $4,941
85 Added 2.27%
3,824 $212,000
Q1 2022

May 16, 2022

SELL
$48.27 - $65.25 $617,083 - $834,156
-12,784 Reduced 77.37%
3,739 $208,000
Q4 2021

Feb 14, 2022

SELL
$59.5 - $67.25 $936,351 - $1.06 Million
-15,737 Reduced 48.78%
16,523 $1.08 Million
Q3 2021

Nov 15, 2021

BUY
$60.19 - $75.29 $1.14 Million - $1.43 Million
18,969 Added 142.72%
32,260 $2.1 Million
Q2 2021

Aug 11, 2021

BUY
$62.12 - $74.2 $620,640 - $741,332
9,991 Added 302.76%
13,291 $977,000
Q1 2021

May 17, 2021

SELL
$57.98 - $73.08 $400,293 - $504,544
-6,904 Reduced 67.66%
3,300 $203,000
Q2 2020

Aug 14, 2020

SELL
$39.55 - $54.65 $713,917 - $986,487
-18,051 Reduced 63.89%
10,204 $541,000
Q4 2017

Feb 14, 2018

SELL
$34.15 - $37.62 $905,179 - $997,155
-26,506 Reduced 48.4%
28,255 $1.06 Million
Q3 2017

Nov 14, 2017

BUY
$30.11 - $37.72 $1.65 Million - $2.07 Million
54,761
54,761 $1.95 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.55B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.